Monday, August 25, 2025
HomeIndustriesBiotechnology

Biotechnology

Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI

Pathos AI, a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, announced its $365 million Series D financing, bringing its post-money...

Recipharm and PLG Form Strategic Alliance to Accelerate Drug Development 

Recipharm, a global leader in contract development and manufacturing (CDMO), has announced a strategic partnership with ProductLife Group (PLG), a prominent provider of product...

ACTO Announces the Next Generation of LAICA The Smartest and Most Personalized AI Knowledge Assistant

Veeva Commercial Summit – ACTO, a long-time Veeva Technology Partner and early member of the Veeva AI Partner Program, announced the upcoming release of...

CytoTronics Expands Pixel Capability with Multi-modal Cardiac Application for Early Screening of Drug Candidates in Cardiovascular Research

CytoTronics, a pioneer of semiconductor-based platforms for discovery in cell biology, launched their novel Cardiac application the next key offering in its Pixel application...

GRAIL and athenahealth Partner to Streamline Ordering of Galleri® Multi-Cancer Early Detection Test

GRAIL, a healthcare company focused on detecting cancer early, when it’s most treatable, announced a strategic partnership with athenahealth, a leading provider of network-enabled...
0FansLike
0FollowersFollow
spot_img

Hot Topics